Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Breban

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Arthritis and Rheumatism|January 5, 2002
Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathyR Said-Nahal, C Miceli-Richard, M A D'Agostino, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registryA Mekinian, P Ravaud, P Y Hatron, et al.
Rheumatology (Oxford, England)|January 30, 2007
Combined analysis of three whole genome linkage scans for Ankylosing SpondylitisK W Carter, A Pluzhnikov, A E Timms, et al.
Arthritis and Rheumatism|June 17, 2000
The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des SpondylarthropathiesR Said-Nahal, C Miceli-Richard, J M Berthelot, et al.
Genes and Immunity|October 22, 2004
DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targetsV Devauchelle, S Marion, N Cagnard, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiographyX Baraliakos, F Heldmann, J Callhoff, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Arthritis and Rheumatism|January 5, 2002
Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathyR Said-Nahal, C Miceli-Richard, M A D'Agostino, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registryA Mekinian, P Ravaud, P Y Hatron, et al.
Rheumatology (Oxford, England)|January 30, 2007
Combined analysis of three whole genome linkage scans for Ankylosing SpondylitisK W Carter, A Pluzhnikov, A E Timms, et al.
Arthritis and Rheumatism|June 17, 2000
The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des SpondylarthropathiesR Said-Nahal, C Miceli-Richard, J M Berthelot, et al.
Genes and Immunity|October 22, 2004
DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targetsV Devauchelle, S Marion, N Cagnard, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiographyX Baraliakos, F Heldmann, J Callhoff, et al.
Pageof 6